Skip to main content
. Author manuscript; available in PMC: 2017 Jul 16.
Published in final edited form as: Cancer Lett. 2017 Jan 13;390:11–20. doi: 10.1016/j.canlet.2017.01.003

Fig. 1. EglN2 is aberrantly expressed in human prostate cancer tissues.

Fig. 1

(A) Representative IHC staining images of EglN2 in prostate tissues. The magnification of upper and lower images is 10× and 200×, respectively. The EglN2 staining was assessed, calculated, plotted and analyzed in (B).*p < 0.05, **p < 0.01 (t test).